CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

GlobeNewswire Clinical Studies
Original article

Mobia Medical Announces Publication of Two-Year Data from VNS-REHAB Trial Demonstrating Durable and Continued Stroke Recovery with Vivistim® Paired VNS™ Therapy

Data ReadoutpositiveVivistim® Paired VNS™ TherapyPositive
AI Analysis

Summary

Mobia Medical announced publication of two-year data from the VNS-REHAB trial in Neurology demonstrating sustained improvements in upper-limb motor function, activities of daily living, and quality of life with Vivistim Paired VNS Therapy for stroke recovery.

Clinical Trial Data

Primary Endpoint

Met

Outcome Details

Two-year data from VNS-REHAB trial published in Neurology showing sustained improvements in upper-limb motor function, activities of daily living, and quality of life

Importance:6/10
Sentiment:
0.75
clinical-datastroke-recoveryneurologyVNS-therapytwo-year-data
Related Companies

Read the original article

Published by GlobeNewswire Clinical Studies on July 14, 2026 8:18 PM

Read Original